Robert Watson

Comment on: ‘Preferences between three options for androgen deprivation therapy…’

Richard J. Wassersug, Robert Watson, Carly S. Sears, Paul F. Schellhammer

Comment on: 'Preferences between three options

ca, ru, us (code pays fourni par la source)

Abstract 4358285: In-Hospital Outcomes of Acute Heart Failure Subtypes in Patients with Breast Cancer: A Nationwide Analysis

Sudeep Nugooru, Artem Oganesyan, Prerana Sevella, Donald C. Haas et autres

Background: Breast cancer (BC) is the most common cause of cancer-related mortality among women. Despite advancements in treatment and longer survival, BC patients are at a higher risk of heart failure (HF) with an increased relative risk of 20% as compared to …

TCT-343 Percutaneous Intervention vs Conservative Therapy for Chronic Total Occlusion (CTO) in Chronic Kidney Disease (CKD): Real-World Outcomes

Muhammad Sabri, Shayan Khan, Hamza Zahid Ullah Muhammadzai, Matthew Collins et autres

us (code pays fourni par la source)

TCT-985 Comparative Outcomes of Percutaneous Versus Surgical Repair for Tricuspid Regurgitation: A Propensity-Matched Analysis

Muhammad Sabri, Shayan Khan, Hamza Zahid Ullah Muhammadzai, Matthew Collins et autres

us (code pays fourni par la source)

Abstract FR494: Impact Of Systemic Hypertension On Cardiovascular Outcomes and Mortality in Cardiac Sarcoidosis Patients: A Real-World Analysis

Muhammad Sabri, Nimra Klair, Eddy Mizrahi, Robert Watson et autres

Introduction: Systemic hypertension (HTN) is prevalent in cardiac sarcoidosis (CS) and may influence long-term outcomes, particularly in patients receiving corticosteroids and calcineurin inhibitors. These treatments can increase susceptibility to elevated blood pressure and HTN crises, further complicating the management of CS. Hypothesis: …

us (code pays fourni par la source)

1638P Dissecting the relationship between response to ICB and CMV status in melanoma

Gusztav Milotay, Martin Little, Robert Watson, Sean Mackay et autres

gb (code pays fourni par la source)

IP26-37 THE CASE FOR, AND CHALLENGES TO, USING TRANSDERMAL ESTRADIOL FOR ANDROGEN DEPRIVATION THERAPY

Robert Watson, Richard J. Wassersug, Paul F. Schellhammer

Abstract 4140711: Efficacy and Safety of Sodium-Glucose Co-transporter-2 Inhibitors in Acute Heart Failure: A Meta-Analysis of Randomized Controlled Trials

Prerana Sevella, Sai Sri Harsha Rallabhandi, Sudeep Nugooru, Shravya Ginnaram et autres

Background: Sodium-glucose co-transporter-2 inhibitors (SGLT2i) have demonstrated benefits in chronic heart failure. Their efficacy in acute decompensated heart failure (ADHF) is not well established, warranting further investigation. This meta-analysis evaluates the impact of SGLT2i (empagliflozin, dapagliflozin, and sotagliflozin) on patients with ADHF. …

us, in (code pays fourni par la source)

Abstract 4139646: Disparities in Palliative Care Utilization Among Patients With Heart Failure and LVAD implantation: A Nationwide Comparative Analysis

Sudeep Nugooru, Shreeja Shah, Prerana Sevella, Shravya Ginnaram et autres

Background: Heart failure (HF) affects 6.7 million Americans and causes 500,000 deaths annually. Despite advancements in treatment, the 1-year mortality in advanced HF is 25-50%. Implantable left ventricular assist devices (LVAD) are critical for bridge-to-transplant or destination therapy, with 1-year and 2-year …

ae, in (code pays fourni par la source)

Abstract 4145588: Evaluating the Cardioprotective Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis of Recent Studies

Sudeep Nugooru, Prerana Sevella, Shravya Ginnaram, Sai Sri Harsha Rallabhandi et autres

Background: Cancer therapies, including anthracyclines and tyrosine kinase inhibitors, can induce cardiotoxic effects, increasing the incidence of heart failure (HF). With improvements in cancer survival rates, the focus has shifted towards minimizing non-cancer-related morbidities and improving overall quality of life. SGLT2 inhibitors …

us (code pays fourni par la source)

CLINICAL QUANDARIES: UNEXPECTED CARDIOMEMS MIGRATION TO THE IVC

Sudeep Nugooru, Prerana Sevella, Muhammad Sabri, Robert Watson

us (code pays fourni par la source)

Severe acute myositis and myocarditis on initiation of 6-weekly pembrolizumab post-COVID-19 mRNA vaccination

Robert Watson, Weiyu Ye, Chelsea Alice Taylor, Elsita Jungkurth et autres

We describe three cases of critical acute myositis with myocarditis occurring within 22 days of each other at a single institution, all within 1 month of receiving the initial cycle of the anti-PD-1 drug pembrolizumab. Analysis of T cell receptor repertoires from …

gb (code pays fourni par la source)